CCAP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Crescent Capital BDC Inc (CCAP) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of significant positive catalysts, weak financial performance, and neutral trading sentiment suggest holding off on investment until clearer growth signals emerge.
The technical indicators are mixed to bearish. The MACD is slightly positive but contracting, RSI is neutral at 36.836, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 12.623), but no strong upward momentum is evident.
Gross margin increased by 1.10% YoY, indicating some operational efficiency improvement.
Analysts have lowered the price target from $14 to $13, reflecting cautious sentiment. No recent news or significant insider/hedge fund activity to drive the stock higher.
In Q4 2025, Crescent Capital BDC reported declining revenue (-8.66% YoY), net income (-15.02% YoY), and EPS (-14.81% YoY). While gross margin improved slightly to 87.37%, overall financial performance shows a downward trend.
Wells Fargo analyst Finian O'Shea lowered the price target from $14 to $13 and maintains an Equal Weight rating, reflecting cautious optimism but no strong bullish sentiment.
